The Current Status of Therapeutic HPV Vaccine
Willemien J. van Driei(Leiden University), Cees J. M. Melief(The Netherlands Cancer Institute), W. Martin Kast(University of Southern California), René E. M. Toes(Leiden University Medical Center), Maaike E. Ressing(Utrecht University), Remco M.P. Brandt(Leiden University), J. Baptist Trimbos(Leiden University), Gert Jan Fleuren(Leiden University Medical Center)
Cited by 20
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
|Journal of Clinical Investigation|2012|708